Bio Essence (BIOE) Income towards Parent Company (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Income towards Parent Company of $205373.0 in Q1 2026, down 80.04% quarter-over-quarter from $1.0 million in Q4 2025, and up 199.82% on a YoY basis from $68499.7 in Q1 2025.
Bio Essence (BIOE) Income towards Parent Company (2020 - 2026) Analysis & Trends
Bio Essence's Income towards Parent Company history runs 7 years deep, the most recent figure standing at $205373.0 for Q1 2026.
- In Q1 2026, Income towards Parent Company rose 199.82% year-over-year to $205373.0; the TTM figure through Mar 2026 stood at $1.3 million (up 500.31% YoY), while the FY2025 annual figure was $896197.0, up 841.72% from the prior year.
- Income towards Parent Company was $205373.0 for Q1 2026 at Bio Essence, down from $1.0 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $1.0 million in Q4 2025 to a low of -$633126.0 in Q3 2023.
- Historically, Income towards Parent Company has averaged $31648.7 across 5 years, with a median of -$120827.0 in 2024.
- Biggest YoY gain for Income towards Parent Company was 808.9% in 2023; the steepest drop was 217.78% in 2023.
- A 5-year view of Income towards Parent Company shows it stood at $68664.0 in 2022, then jumped by 808.9% to $624087.0 in 2023, then sank by 119.36% to -$120827.0 in 2024, then jumped by 951.7% to $1.0 million in 2025, then plunged by 80.04% to $205373.0 in 2026.
- The last three Income towards Parent Company figures came in at $205373.0 (Q1 2026), $1.0 million (Q4 2025), and $12998.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Bio Essence | - | - | 319,353.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205,373.00 |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 12,998.00 |
| Jun 30, 2025 | 59,864.00 |
| Mar 31, 2025 | -205,752.00 |
| Sep 30, 2024 | -120,827.00 |
| Mar 31, 2024 | 377,752.00 |
| Dec 31, 2023 | 624,087.00 |
| Sep 30, 2023 | -633,126.00 |
| Jun 30, 2023 | -191,072.00 |
| Mar 31, 2023 | -155,772.00 |
| Dec 31, 2022 | 68,664.00 |
| Sep 30, 2022 | -199,233.00 |
| Jun 30, 2022 | -164,193.00 |
| Mar 31, 2022 | -233,120.00 |
| Dec 31, 2021 | -90,634.00 |
| Sep 30, 2021 | -183,037.00 |
| Jun 30, 2021 | -163,538.00 |
| Mar 31, 2021 | -210,355.00 |
| Dec 31, 2020 | -89,542.00 |